Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy ; volume:37 ; number:5 ; day:6 ; month:5 ; year:2023 ; pages:675-684 ; date:9.2023
BioDrugs ; 37, Heft 5 (6.5.2023), 675-684, 9.2023
- Creator
-
Ciccimarra, Francesco
Luxi, Nicoletta
Bellitto, Chiara
L’ Abbate, Luca
Nardo, Pasquale De
Savoldi, Alessia
Yeomans, Alison
Molokhia, Mariam
Tacconelli, Evelina
Trifirò, Gianluca
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-023-00601-w
- URN
-
urn:nbn:de:101:1-2023110413155100275225
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ciccimarra, Francesco
- Luxi, Nicoletta
- Bellitto, Chiara
- L’ Abbate, Luca
- Nardo, Pasquale De
- Savoldi, Alessia
- Yeomans, Alison
- Molokhia, Mariam
- Tacconelli, Evelina
- Trifirò, Gianluca
- SpringerLink (Online service)
Other Objects (12)
Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model
Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study
Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model
Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study
Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model
Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials